Earnings Reports for the Week of Jan. 13-17 (DAL, JPM, UNH)

Below is a weekly earnings calendar of the most important upcoming quarterly reports schedule to be released by publicly traded companies. There are also earnings previews for select companies. Please check back often. This earnings calendar is updated weekly.

Earnings Calendar Highlights

MONDAY

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Noteworthy Earnings Reports: Shaw Communications (SJR)” data-reactid=”19″>Noteworthy Earnings Reports: Shaw Communications (SJR)

<h3 class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SEE ALSO: Dogs of the Dow 2020: 10 Dividend Stocks to Watch” data-reactid=”20″>SEE ALSO: Dogs of the Dow 2020: 10 Dividend Stocks to Watch

TUESDAY

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Earnings Spotlight: Delta Air Lines (DAL, $58.96) – Delta’s shares have been more volatile and less productive than the overall market over the past year, but they’ve still accumulated 22% in gains in that time. The stock will have a chance to extend that rally ahead of the Jan. 14 opening bell, when it reports the results of its December quarter. The company left a few analysts encouraged following its December investor-day event, including Buckingham’s Daniel McKenzie (Neutral, equivalent of Hold), who raised his price target from $56 per share to $62, citing strong operational and financial executions. He does, however, warn of several short-term headwinds, including an open pilot contract and a switch in Japan hubs from Narita to Haneda. Stifel’s Joseph DeNardi (Buy, $90 PT) is far more optimistic. He calls the company’s transition to better financial disclosures, starting in June 2020, "a potential nearish-term positive catalyst and … enormously important for the longer-term." For the quarter to be reported, Wall Street’s pros are looking for a 5.6% year-over-year improvement in revenues, to $11.35 billion, and a 7.7% bump in earnings per share, to $1.40. That should result in full-year revs of $46.92 billion (+5.6%) and EPS of $7.01 (+24.1%).” data-reactid=”22″>Earnings Spotlight: Delta Air Lines (DAL, $58.96) – Delta’s shares have been more volatile and less productive than the overall market over the past year, but they’ve still accumulated 22% in gains in that time. The stock will have a chance to extend that rally ahead of the Jan. 14 opening bell, when it reports the results of its December quarter. The company left a few analysts encouraged following its December investor-day event, including Buckingham’s Daniel McKenzie (Neutral, equivalent of Hold), who raised his price target from $56 per share to $62, citing strong operational and financial executions. He does, however, warn of several short-term headwinds, including an open pilot contract and a switch in Japan hubs from Narita to Haneda. Stifel’s Joseph DeNardi (Buy, $90 PT) is far more optimistic. He calls the company’s transition to better financial disclosures, starting in June 2020, “a potential nearish-term positive catalyst and … enormously important for the longer-term.” For the quarter to be reported, Wall Street’s pros are looking for a 5.6% year-over-year improvement in revenues, to $11.35 billion, and a 7.7% bump in earnings per share, to $1.40. That should result in full-year revs of $46.92 billion (+5.6%) and EPS of $7.01 (+24.1%).

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Earnings Spotlight: JPMorgan Chase (JPM, $137.44) – JPMorgan will join Delta in reporting ahead of Thursday’s open, unofficially kicking off earnings season for financial stocks. While shares have easily outperformed the market with a 36% gain over the past year – versus 27% for the S&amp;P 500 – that has a few analysts cooling on the stock’s future prospects. Analysts from Wolfe Research and UBS downgraded JPM shares over the past few days. The latter’s Saul Martinez dropped the stock from Buy to Neutral, but raised his price target from $132 to $138, given its "premium" valuation compared to its peers. The only way he sees considerable upside ahead is if return on tangible common equity (ROTCE) reaches levels "not generated by large US banks since the immediate aftermath of the financial crisis." For its fourth quarter, the analyst community is looking for a 4.2% increase in revenues to $27.92 billion and an 18.2% pop in profits to $2.34 per share. Full-year estimates are for $116.07 billion in revenues (+4.1%) and $10.48 in EPS (+16.4%).” data-reactid=”23″>Earnings Spotlight: JPMorgan Chase (JPM, $137.44) – JPMorgan will join Delta in reporting ahead of Thursday’s open, unofficially kicking off earnings season for financial stocks. While shares have easily outperformed the market with a 36% gain over the past year – versus 27% for the S&P 500 – that has a few analysts cooling on the stock’s future prospects. Analysts from Wolfe Research and UBS downgraded JPM shares over the past few days. The latter’s Saul Martinez dropped the stock from Buy to Neutral, but raised his price target from $132 to $138, given its “premium” valuation compared to its peers. The only way he sees considerable upside ahead is if return on tangible common equity (ROTCE) reaches levels “not generated by large US banks since the immediate aftermath of the financial crisis.” For its fourth quarter, the analyst community is looking for a 4.2% increase in revenues to $27.92 billion and an 18.2% pop in profits to $2.34 per share. Full-year estimates are for $116.07 billion in revenues (+4.1%) and $10.48 in EPS (+16.4%).

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Other Noteworthy Reports: Aphria (APHA), Citigroup (C), IHS Markit (INFO), Wells Fargo (WFC), Wipro (WIT)” data-reactid=”24″>Other Noteworthy Reports: Aphria (APHA), Citigroup (C), IHS Markit (INFO), Wells Fargo (WFC), Wipro (WIT)

WEDNESDAY

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Earnings Spotlight: UnitedHealth Group (UNH, $294.22) – America’s largest health insurer has had a volatile year while investors keep guessing at the future of the nation’s health-care system following the 2020 elections. But Wall Street isn’t wavering. Over the past three months, 20 analysts have sounded off on the stock, and 17 of those have been Buys. That includes Goldman Sachs’ Stephen Tanal, which upgraded the stock from Buy to the firm’s Conviction Buy list and hiked his price target from $300 per share to $330. He cites the company’s strong positioning in Medicaid and Medicare Advantage, and says its operating cash flow this year will "handily cover" its planned capital expenses, which should allow it to buy back stock and make "tuck-in" acquisitions. Argus’ David Toung (Buy, $340 PT) also chimed in last month, expecting the repeal of the Health Insurer Fee tax to spur hotter earnings growth starting in 2021. UNH’s fourth-quarter results, expected ahead of the Jan. 15 open, should include a 4.5% climb in revenues to $61.06 billion, and 14.9% higher earnings to $3.77 per share. Full-year estimates are for $242.3 billion in revenues (+7.1%) and $14.98 in EPS (+16.3%).” data-reactid=”26″>Earnings Spotlight: UnitedHealth Group (UNH, $294.22) – America’s largest health insurer has had a volatile year while investors keep guessing at the future of the nation’s health-care system following the 2020 elections. But Wall Street isn’t wavering. Over the past three months, 20 analysts have sounded off on the stock, and 17 of those have been Buys. That includes Goldman Sachs’ Stephen Tanal, which upgraded the stock from Buy to the firm’s Conviction Buy list and hiked his price target from $300 per share to $330. He cites the company’s strong positioning in Medicaid and Medicare Advantage, and says its operating cash flow this year will “handily cover” its planned capital expenses, which should allow it to buy back stock and make “tuck-in” acquisitions. Argus’ David Toung (Buy, $340 PT) also chimed in last month, expecting the repeal of the Health Insurer Fee tax to spur hotter earnings growth starting in 2021. UNH’s fourth-quarter results, expected ahead of the Jan. 15 open, should include a 4.5% climb in revenues to $61.06 billion, and 14.9% higher earnings to $3.77 per share. Full-year estimates are for $242.3 billion in revenues (+7.1%) and $14.98 in EPS (+16.3%).

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Other Noteworthy Reports: Alcoa (AA), Bank of America (BAC), BlackRock (BLK), Goldman Sachs (GS), Kinder Morgan (KMI), PNC Financial Services (PNC), U.S. Bancorp (USB)” data-reactid=”27″>Other Noteworthy Reports: Alcoa (AA), Bank of America (BAC), BlackRock (BLK), Goldman Sachs (GS), Kinder Morgan (KMI), PNC Financial Services (PNC), U.S. Bancorp (USB)

<h3 class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SEE ALSO: Pros’ Picks: The 13 Best Dividend Stocks for 2020” data-reactid=”28″>SEE ALSO: Pros’ Picks: The 13 Best Dividend Stocks for 2020